Analysts' Actions: INTC ONXX VRSN Z RHAT

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Forestar Group ( FOR) was upgraded to buy at TheStreet Ratings.

Northeast Bancorp ( NBN) was downgraded to hold at TheStreet Ratings.

Intel ( INTC) earnings estimates were reduced at UBS. The lowered outlook reflects a sub-seasonal PC client trend, said UBS. Price target remains $22.50.

Onyx Pharmaceuticals ( ONXX) price target was increased to $105 by JPMorgan. Palbociclib (palbo, or PD-991), a breast cancer drug, is now included in the valuation, said JPMorgan.

Verisign ( VRSN) price target was increased to $50 at Citigroup. The new price target reflects the likelihood of a significant debt raise, said Citigroup.

Zillow ( Z) price target increased at Citi. The initial mid-term outlook provided at Z's fist analyst day led to a new price target of $70, said Citigroup.

Red Hat ( RHAT) estimates and price target cut at MKM. RHT earnings estimates through 2014 were reduced on management guidance, said MKM Partners. The new price target is $53.

Progress Software ( PRGS) price target was reduced to $29 at Benchmark. Lower fiscal 2Q guidance reflects uncertainty related to its ongoing business transformation, said Benchmark.

If you liked this article you might like

Buying Nvidia Now Is Like Getting Intel Way Back in 1993, Jim Cramer Says

Amazon, Google and Other U.S. Tech Giants Face a Battle Over Taxes With Europe

S&P 500 and Dow on Track for Records With Markets in Good Mood Ahead of Fed

Cramer: Nvidia Is More Than Just a Pet Name

10 Biggest Takeaways from Apple's iPhone X Event